The Cooper Companies, Inc. (COO)
Why Is The Cooper Companies (COO) Up 0.2% Since Last Earnings Report?
The Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock?
Early Anthropic hire, former METR COO have found a way to rein in rogue AI agents
A day after Anthropic researcher Jacob Coxon quit his job over concerns that AI could kill us all by the end of the decade, I met with founders and brothers-in-law Rune Kvist and Rajiv Dattani. They think they have a solution that could save us all, or at least help prevent AI agents from going rogue inside enterprises.
Cooper Companies: A Little More Compelling At This Price
Cooper Companies (COO) is re-rated from Sell to Hold after a 31% price decline, reflecting a more interesting risk/reward profile but ongoing growth concerns. COO's revenue growth remains weak, with core CooperVision revenues flat and management attributing this to distribution channel destocking, raising questions about underlying demand. Gross margin expansion to 67% is largely driven by inventory write-offs, making COO's margin improvement less robust than Alcon's operational gains.
Cooper Cos. Stock Drops After Soft Outlook, News It Won't Seek Deal
Shares of Cooper Cos. are pacing the S&P 500's decliners Thursday after the maker of medical devices reported mixed results, issued soft guidance and wrapped up a strategic review without plans to seek a deal.
2 Medical-Device Stocks Lighting Up the Options Pits
Medical-device stocks Cooper Companies Inc (NASDAQ:COO) and Axogen Inc (NASDAQ:AXGN) are both sharply lower following separate company developments, and options traders are chiming in.
2 Reasons Cooper Companies Stock Is By Far the Worst in the S&P 500 Today
The contact lens maker just sprung a surprise no one saw coming.
Cooper Companies Q3 Earnings Call Highlights
Cooper Companies NASDAQ: COO reported third-quarter fiscal 2026 revenue of $1.066 billion, up about 1% on both a reported and organic basis, as record free cash flow and earnings growth offset pressure at its CooperVision contact lens business from planned U.S. channel inventory reductions.
The Cooper Companies (COO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for The Cooper Companies (COO) give a sense of how the business performed in the quarter ended July 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The Cooper Companies (COO) Beats Q3 Earnings Estimates
The Cooper Companies (COO) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.1 per share a year ago.
Countdown to The Cooper Companies (COO) Q3 Earnings: Wall Street Forecasts for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for The Cooper Companies (COO), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.
COO vs. MMSI: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and Merit Medical (MMSI). But which of these two stocks is more attractive to value investors?
Wendy's Jumps 5% on Nelson Peltz Take-Private Report, COO Role Revival
Shares of Wendy's (NASDAQ:WEN | WEN Price Prediction) are up 5% to $8.88 in midday trading Wednesday after reports that Nelson Peltz's Trian Fund Management is assembling a consortium to take the company private.
